It’s ironic that the Axovant deal (when we had it) did nothing for our stock price for over a year. We languished at all time lows. Now Axovant has published promising results in its other programs and it has had no effect on its valuation. In fact the company share price has fallen significantly over the last twelve months - even after a reverse split.
I’m guessing that in the near future Benitec will accelerate the OPMD program and its star will start to shine and share price rise while Axovant will continue to languish. If you believe in the value of the OPMD program then now is the time to enter because of the uncertainty surrounding the termination of the Axovant-Benitec contract.
OPMD for seven cents - yes please. And there are other ddrnai programs to be announced soon.
Add to My Watchlist
What is My Watchlist?